← Back to Search

Feedback Interventions + Text Messages for Alcohol Use Disorder (MC2 Trial)

N/A

Waitlist Available

Led By Mary E Larimer, PhD

Research Sponsored by University of Washington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Must not have

Unwillingness to participate

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 24 months of assessment

Awards & highlights

No Placebo-Only Group

Summary

This trial looks at whether it's better to present all parts of a medical intervention at once, or one at a time over several weeks.

Who is the study for?

This study is for individuals who have experienced negative consequences from alcohol use, as measured by specific tests, and engage in heavy drinking episodes. Participants must own a cell phone capable of receiving text messages and be willing to receive them. Those planning international travel soon or unwilling to consent are excluded.

What is being tested?

The trial is testing two ways of delivering feedback on alcohol use: all at once (traditional) versus over several weeks (sequential). It also examines the effectiveness of follow-up text message boosters in influencing participants' behavior regarding alcohol consumption.

What are the potential side effects?

Since this trial involves personalized feedback and text messaging interventions rather than medication, traditional side effects are not applicable. However, participants may experience discomfort or stress related to self-reflection on their alcohol use.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am willing to participate in the clinical trial.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 24 months of assessment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~24 months of assessment

This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months of assessment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change from Baseline Alcohol Use at 12 months

Change from Baseline Alcohol Use at 18 months

Change from Baseline Alcohol Use at 24 months

+1 more

Secondary study objectives

Alcohol Use during Birthday

Alcohol Use during Spring Break

Alcohol Use on 4th of July

+2 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

5Treatment groups

Experimental Treatment

Active Control

Group I: Simultaneous Post Feedback Information Delivery +Text MessagesExperimental Treatment2 Interventions

Participants receive all 4 feedback components immediately after providing consent to the Pilot Feasibility Study following the Screening/Baseline Survey. Participants complete a brief 10 minute Post-Feedback Survey and a 3 Week Followup Survey to assess knowledge of the intervention feedback content. Additionally, participants receive the Text Message Booster Component in the days before and during the high risk drinking event celebration(s).

Group II: Simultaneous Post Feedback Information DeliveryExperimental Treatment1 Intervention

Group III: Sequential Post Feedback Information Delivery +Text MessagesExperimental Treatment2 Interventions

Participants receive the first component of their PFI immediately following Baseline and subsequently receive 1 component each week until they receive all 4 components. Participants will complete a Post Feedback Survey and a 3 week follow back and Knowledge assessment. Additionally, participants receive the Text Message Booster Component in the days before and during the high risk drinking event celebration(s).

Group IV: Sequential Post Feedback Information DeliveryExperimental Treatment1 Intervention

Group V: Assessment Only ControlActive Control1 Intervention

Participants complete baseline survey, longitudinal follow up assessments, and pre- and post- event surveys.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Text Message Boosters

2018

N/A

~250

0 / 1Eligibility criteria met